John Volpone
Förmögenhet: 1 M $ per 2026-07-31
Förmögenhet: 1 M $ per 2026-07-31
John Volpone is currently Chief Operating Officer at X4 Pharmaceuticals, Inc. Formerly, Mr. Volpone was Director-Business Development at ZymoGenetics, Inc. and Senior Vice President-Strategic Operations at.
CTI BioPharma Corp.
Education includes an undergraduate degree from the University of Washington and an MBA from Seattle University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
X4 PHARMACEUTICALS, INC. 0,28 % | 2026-08-12 | 265 305 ( 0,28 % ) | 1 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Verksamhetschef | 2025-09-16 |
| Företag | Position | Slut |
|---|---|---|
| CTI BIOPHARMA CORP. | Personalchef | 2023-10-01 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seattle University
Seattle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån